AngioDynamics Piotroski F Score
ANGO Stock  USD 12.07 0.22 1.79% 
AngioDynamics  Piotroski F Score 
At this time, it appears that AngioDynamics' Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski FScore model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient longterm portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score  Poor
1  Current Return On Assets  Negative  Focus 
2  Change in Return on Assets  Decreased  Focus 
3  Cash Flow Return on Assets  Negative  Focus 
4  Current Quality of Earnings (accrual)  Improving  Focus 
5  Asset Turnover Growth  Decrease  Focus 
6  Current Ratio Change  Increase  Focus 
7  Long Term Debt Over Assets Change  Higher Leverage  Focus 
8  Change In Outstending Shares  Decrease  Focus 
9  Change in Gross Margin  Increase  Focus 
AngioDynamics Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to AngioDynamics is to make sure AngioDynamics is not a subject of accounting manipulations and runs a healthy internal audit department. So, if AngioDynamics' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if AngioDynamics' financial numbers are properly reported.
Current Value  Last Year  Change From Last Year  10 Year Trend  

Weighted Average Shares Diluted  44.3 M  44.9 M 

 
Weighted Average Shares  44.3 M  44.9 M 

 
Return on Average Assets  (0.0466)  (0.0432) 

 
Net Cash Flow from Operations  (6.6 M)  (6.5 M) 

 
Current Liabilities  81.7 M  85.5 M 

 
Total Liabilities  142.6 M  115.4 M 

 
Gross Margin  0.62  0.6 

 
Total Debt  23.1 M  22.5 M 

 
Asset Turnover  0.6  0.66 

 
Current Assets  182.7 M  164.8 M 

 
Total Assets  559.2 M  497.5 M 


AngioDynamics F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between AngioDynamics' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards AngioDynamics in a muchoptimized way.
Click cells to compare fundamentals
About AngioDynamics Piotroski F Score
FScore is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his FScore binary model can help to predict the performance of low pricetobook stocks.Book Value per Share 

AngioDynamics Current Valuation Drivers
We derive many important indicators used in calculating different scores of AngioDynamics from analyzing AngioDynamics' financial statements. These drivers represent accounts that assess AngioDynamics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AngioDynamics' important valuation drivers and their relationship over time.
2018  2019  2020  2021  2022  2023 (projected)  
Net Income Per Employee  81.79 K  (207.91 K)  (39.44 K)  (34.93 K)  (40.17 K)  (41.23 K)  
Revenue Per Employee  360.85 K  329.29 K  363.76 K  416.08 K  374.47 K  323.42 K  
Average Assets  773.02 M  685.35 M  578.99 M  551.45 M  496.3 M  553.04 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  88.76 M  (141.35 M)  (6.82 M)  2.53 M  2.27 M  2.33 M  
Earnings Before Interest Taxes and Depreciation Amortization USD  88.76 M  (141.35 M)  (6.82 M)  2.53 M  2.27 M  2.33 M  
Earnings before Tax  57.78 M  (168.13 M)  (36.05 M)  (29.95 M)  (26.95 M)  (29.08 M)  
Average Equity  565.84 M  573.31 M  450.95 M  430.62 M  387.56 M  420.27 M  
Enterprise Value  790.67 M  372.04 M  857.27 M  762.36 M  876.72 M  823.76 M  
Free Cash Flow  34.32 M  (21.79 M)  10.38 M  (22.9 M)  (20.61 M)  (21.15 M)  
Invested Capital  174.35 M  130.68 M  105.4 M  121.16 M  109.05 M  149 M  
Invested Capital Average  206.67 M  95.12 M  124.83 M  125.48 M  112.93 M  148.68 M  
Market Capitalization  699.29 M  384.86 M  881.74 M  761.25 M  875.44 M  790.3 M  
Tangible Asset Value  343.38 M  196.56 M  191.15 M  199.31 M  179.38 M  193.4 M  
Working Capital  241.99 M  101.47 M  83.3 M  69.02 M  79.37 M  101 M 
About AngioDynamics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioDynamics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people.
AngioDynamics Investors Sentiment
The influence of AngioDynamics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in AngioDynamics. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to AngioDynamics' public news can be used to forecast risks associated with investment in AngioDynamics. The trend in average sentiment can be used to explain how an investor holding AngioDynamics can time the market purely based on public headlines and social activities around AngioDynamics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
AngioDynamics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AngioDynamics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AngioDynamics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on AngioDynamics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving together with AngioDynamics
+  0.61  VNRX  Volitionrx  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.67  ENSG  Ensign Group  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.68  NVRO  Nevro Corp  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.76  ABT  Abbott Laboratories  Fiscal Quarter End 31st of March 2023  PairCorr 
Moving against AngioDynamics
  0.6  MLSS  Milestone Scientific  Earnings Call This Week  PairCorr  
  0.7  OSUR  OraSure Technologies  Fiscal Quarter End 31st of March 2023  PairCorr 
The ability to find closely correlated positions to AngioDynamics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Check out AngioDynamics Altman Z Score, AngioDynamics Correlation, AngioDynamics Valuation, as well as analyze AngioDynamics Alpha and Beta and AngioDynamics Hype Analysis. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of meanvariance optimization against your current asset allocation  
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device  
Volatility Analysis Get historical volatility and risk analysis based on latest market data  
Analyst Recommendations Analyst recommendations and target price estimates broken down by several categories  
Global Correlations Find global opportunities by holding instruments from different markets  
Portfolio Rebalancing Analyze riskadjusted returns against different time horizons to find assetallocation targets  
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account  
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities 
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84)  Revenue Per Share 8.353  Quarterly Revenue Growth 0.091  Return On Assets (0.0247)  Return On Equity (0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.